Drug Type Small molecule drug |
Synonyms Galodif, Halodif |
Target |
Mechanism CYPs modulators(Cytochrome P450 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H13ClN2O |
InChIKeyVQPUSIQKYOCUMK-UHFFFAOYSA-N |
CAS Registry117211-21-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alcoholism | Phase 2 | - | - | |
Alcoholism | Phase 2 | - | - | |
Alcoholism | Phase 2 | - | - | |
Epilepsy | Phase 2 | - | - | |
Epilepsy | Phase 2 | - | - | |
Epilepsy | Phase 2 | - | - |